These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 12374430)

  • 21. Clinical neurotransplantation protocol for Huntington's and Parkinson's disease.
    Lopez WO; Nikkhah G; Kahlert UD; Maciaczyk D; Bogiel T; Moellers S; Schültke E; Döbrössy M; Maciaczyk J
    Restor Neurol Neurosci; 2013; 31(5):579-95. PubMed ID: 23777636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell therapy for Parkinson's disease.
    Fischbach GD; McKhann GM
    N Engl J Med; 2001 Mar; 344(10):763-5. PubMed ID: 11236783
    [No Abstract]   [Full Text] [Related]  

  • 23. Grafts and growth factors in CNS. Basic science with clinical promise.
    Olson L
    Stereotact Funct Neurosurg; 1990; 54-55():250-67. PubMed ID: 2080339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.
    Mendez I; Sanchez-Pernaute R; Cooper O; Viñuela A; Ferrari D; Björklund L; Dagher A; Isacson O
    Brain; 2005 Jul; 128(Pt 7):1498-510. PubMed ID: 15872020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The future of cell-based transplantation therapies for neurodegenerative disorders.
    Lazic SE; Barker RA
    J Hematother Stem Cell Res; 2003 Dec; 12(6):635-42. PubMed ID: 14977473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dyskinesias after transplantation in Parkinson's disease.
    Piccini P
    Lancet Neurol; 2002 Dec; 1(8):472. PubMed ID: 12849327
    [No Abstract]   [Full Text] [Related]  

  • 27. How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson's disease?
    Liu J; Huang HY
    Neurosci Bull; 2007 Nov; 23(6):377-82. PubMed ID: 18064069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trials offer way forward for Parkinson's.
    Abbott A
    Nature; 2001 Mar; 410(6827):401. PubMed ID: 11260676
    [No Abstract]   [Full Text] [Related]  

  • 29. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.
    Politis M; Wu K; Loane C; Quinn NP; Brooks DJ; Rehncrona S; Bjorklund A; Lindvall O; Piccini P
    Sci Transl Med; 2010 Jun; 2(38):38ra46. PubMed ID: 20592420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.
    Carlsson T; Winkler C; Lundblad M; Cenci MA; Björklund A; Kirik D
    Neurobiol Dis; 2006 Mar; 21(3):657-68. PubMed ID: 16256359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results.
    Kirik D; Björklund A
    Brain; 2005 Jul; 128(Pt 7):1478-9. PubMed ID: 15980119
    [No Abstract]   [Full Text] [Related]  

  • 32. Neural grafting in Parkinson's disease Problems and possibilities.
    Brundin P; Barker RA; Parmar M
    Prog Brain Res; 2010; 184():265-94. PubMed ID: 20887880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can human fetal cortical brain tissue transplant (up to 20 weeks) sustain its metabolic and oxygen requirements in a heterotopic site outside the brain? A study of 12 volunteers with Parkinson's disease.
    Bhattacharya N; Chhetri MK; Mukherjee KL; Ghosh AB; Samanta BK; Mitra R; Bhattacharya M; Bhattacharya S; Bandopadhyaya T
    Clin Exp Obstet Gynecol; 2002; 29(4):259-66. PubMed ID: 12635741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson's disease.
    Mamelak AN; Eggerding FA; Oh DS; Wilson E; Davis RL; Spitzer R; Hay JA; Caton WL
    J Neurosurg; 1998 Oct; 89(4):592-8. PubMed ID: 9761053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular replacement of dopamine deficit in Parkinson's disease using human fetal mesencephalic tissue: preliminary results in four patients.
    Redmond DE; Robbins RJ; Naftolin F; Marek KL; Vollmer TL; Leranth C; Roth RH; Price LH; Gjedde A; Bunney BS
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():325-59. PubMed ID: 8417471
    [No Abstract]   [Full Text] [Related]  

  • 36. Improving the survival of grafted dopaminergic neurons: a review over current approaches.
    Brundin P; Karlsson J; Emgård M; Schierle GS; Hansson O; Petersén A; Castilho RF
    Cell Transplant; 2000; 9(2):179-95. PubMed ID: 10811392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stem cell transplantation: a promising therapy for Parkinson's disease.
    Wang Y; Chen S; Yang D; Le WD
    J Neuroimmune Pharmacol; 2007 Sep; 2(3):243-50. PubMed ID: 18040857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.
    Piccini P; Brooks DJ; Björklund A; Gunn RN; Grasby PM; Rimoldi O; Brundin P; Hagell P; Rehncrona S; Widner H; Lindvall O
    Nat Neurosci; 1999 Dec; 2(12):1137-40. PubMed ID: 10570493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkinson's research. Fetal cell transplant trial draws fire.
    Vogel G
    Science; 2001 Mar; 291(5511):2060-1. PubMed ID: 11256388
    [No Abstract]   [Full Text] [Related]  

  • 40. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
    Olanow CW; Goetz CG; Kordower JH; Stoessl AJ; Sossi V; Brin MF; Shannon KM; Nauert GM; Perl DP; Godbold J; Freeman TB
    Ann Neurol; 2003 Sep; 54(3):403-14. PubMed ID: 12953276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.